ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025
Pulmonary rehabilitation improves distance-saturation product in IPF: Greater benefits in patients with exercise-induced desaturation.
Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimExercise-induced dyspnea and desaturation are hallmark features of idiopathic pulmonary fibrosis (IPF) and are linked to disease severity and poor outcomes. The distance-saturation product (DSP), calculated by multiplying the walking distance by oxygen saturation, has been proposed as a mortality predictor. This study aimed to investigate the effects of a pulmonary rehabilitation (PR) program on clinical outcomes and DSP in two IPF patient groups: those with and without desaturation during the six-minute walk test (6MWT).
methodsIPF patients who completed a standardized PR program were included. Assessments before and after PR included spirometry, arterial blood gas analysis, Medical Research Council (MRC) dyspnea scale, 6MWT, St. George's Respiratory Questionnaire (SGRQ), 36-Item Short Form Survey (SF-36), and Hospital Anxiety and Depression Scale (HADS). DSP was calculated at the end of the 6MWT. Patients with oxygen saturation ≤88% during baseline 6MWT were assigned to the desaturated group; others were assigned to the non-desaturated group.
resultsFifty patients were enrolled (20 desaturated, 30 non-desaturated). Following PR, only the desaturated group showed significant improvements in forced vital capacity (FVC), oxygen saturation, and SF-36 domains. In both groups, PaO₂, 6MWT distance, and DSP increased significantly, while MRC, SGRQ, and HADS scores decreased. However, the gains in 6MWT distance and DSP were significantly greater in the desaturated group.
conclusionPR improved functional, psychological, and quality-of-life outcomes in both groups, with more pronounced benefits on sa in desaturated patients. Referral to PR is especially recommended for this subgroup.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.